Cancer Support Group

Thursday, Apr 15th

Last update:06:42:40 AM GMT

Home News and Update Year 2009 Integrin Signaling Inhibits Paclitaxel-induced Apoptosis in Breast Cancer Cells

Integrin Signaling Inhibits Paclitaxel-induced Apoptosis in Breast Cancer Cells

Inherent or acquired drug resistance is one of the major problems in chemotherapy. The mechanisms by which cancer cells survive and escape the cytotoxic effects of chemotherapeutic agents are essentially unknown. In the present study, we demonstrate that in the MDA–MB–231 and MDA–MB–435 breast cancer cells, ligation of beta1 integrins by their extracellular matrix ligands inhibits significantly apoptosis induced by paclitaxel and vincristine, two microtubule–directed chemotherapeutic agents that are widely used in the therapy of breast cancer. We show that beta1 integrin signaling inhibits drug–induced apoptosis by inhibiting the release of cytochrome c from the mitochondria in response to drug treatment. Further, integrin–mediated protection from drug–induced apoptosis and inhibition of cytochrome c release are dependent on the activation of the PI 3–kinase/Akt pathway. Our results identify beta1 integrin signaling as an important survival pathway in drug–induced apoptosis in breast cancer cells and suggest that activation of this pathway may contribute to the generation of drug resistance.


Disclaimer: The article on this page is the copyright of the cited publication.This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing’ or ‘Fair use’. Visitors may click on the publication name, in the article, to visit the original article as it appears on the publication’s website.


This is YOUR sites, so if you have suggestions or feedback on how we can improve it for you, please let us know! We do our best to keep up!

Make a Suggestion
Manthan Award

Link to Aarogya

aarogya logo